| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
SH3 and multiple ankyrin repeat domains 3 | 0.550 | 0.731 | 1.00 |
|
disease | 0.700 | None | 1.000 | 0 | 0 | 2010 | 2019 | ||||||||
|
reticulon 4 receptor | 0.595 | 0.692 | 0.96 |
|
disease | 0.670 | None | 0.857 | 0 | 0 | 2004 | 2017 | ||||||||
|
D-amino acid oxidase activator | 0.678 | 0.346 | 1.4E-04 |
|
disease | 0.500 | None | 0.965 | 0 | 0 | 2002 | 2018 | ||||||||
|
disrupted in schizophrenia 2 | 0.716 | 0.192 |
|
disease | 0.500 | None | 1.000 | 0 | 0 | 2001 | 2010 | |||||||||
|
solute carrier family 1 member 1 | 0.561 | 0.654 | 8.7E-06 |
|
disease | 0.500 | None | 1.000 | 0 | 0 | 2001 | 2018 | ||||||||
|
chitinase 3 like 1 | 0.419 | 0.885 | 1.1E-05 |
|
disease | 0.500 | None | 0.900 | 0 | 0 | 2003 | 2019 | ||||||||
|
synapsin II | 0.653 | 0.577 |
|
disease | 0.490 | None | 0.889 | 0 | 0 | 2000 | 2019 | |||||||||
|
apolipoprotein L2 | 0.722 | 0.308 | 7.3E-03 |
|
disease | 0.410 | None | 1.000 | 0 | 0 | 2013 | 2013 | ||||||||
|
apolipoprotein L4 | 0.839 | 0.231 | 1.1E-03 |
|
disease | 0.400 | None | 0 | 0 | |||||||||||
|
membrane associated guanylate kinase, WW and PDZ domain containing 2 | 0.579 | 0.654 | 1.00 |
|
disease | 0.850 | None | 1.000 | 1 | 0 | 2008 | 2018 | ||||||||
|
glutamate ionotropic receptor NMDA type subunit 2B | 0.510 | 0.692 | 1.00 |
|
disease | 0.700 | None | 0.972 | 1 | 0 | 2000 | 2020 | ||||||||
|
nitric oxide synthase 1 | 0.408 | 0.885 | 1.00 |
|
disease | 0.700 | None | 0.964 | 1 | 0 | 1995 | 2019 | ||||||||
|
Sp4 transcription factor | 0.711 | 0.423 | 0.99 |
|
disease | 0.660 | None | 1.000 | 1 | 0 | 2005 | 2019 | ||||||||
|
cannabinoid receptor 1 | 0.446 | 0.808 | 0.51 |
|
disease | 0.600 | None | 0.951 | 1 | 0 | 2000 | 2019 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
disease | 0.600 | None | 0.780 | 1 | 0 | 1995 | 2019 | ||||||||
|
dystrobrevin binding protein 1 | 0.588 | 0.615 | 6.8E-06 |
|
disease | 0.600 | None | 0.948 | 1 | 0 | 2002 | 2019 | ||||||||
|
neuregulin 3 | 0.670 | 0.615 | 0.11 |
|
disease | 0.600 | None | 0.786 | 1 | 0 | 2008 | 2020 | ||||||||
|
solute carrier family 6 member 3 | 0.453 | 0.885 | 1.00 |
|
disease | 0.600 | None | 0.964 | 1 | 0 | 1993 | 2020 | ||||||||
|
phospholipase C beta 1 | 0.595 | 0.654 | 0.98 |
|
disease | 0.540 | None | 1.000 | 1 | 0 | 2008 | 2019 | ||||||||
|
solute carrier family 6 member 1 | 0.592 | 0.538 | 1.00 |
|
disease | 0.540 | None | 1.000 | 1 | 0 | 2001 | 2015 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
disease | 0.530 | None | 1.000 | 1 | 0 | 2011 | 2019 | ||||||||
|
neurogranin | 0.608 | 0.615 | 0.48 |
|
disease | 0.500 | None | 0.967 | 1 | 0 | 2008 | 2019 | ||||||||
|
dopamine receptor D3 | 0.529 | 0.692 | 2.4E-03 |
|
disease | 0.500 | None | 0.841 | 1 | 0 | 1992 | 2020 | ||||||||
|
proline dehydrogenase 1 | 0.612 | 0.692 | 5.4E-12 |
|
disease | 0.500 | None | 0.955 | 1 | 0 | 2004 | 2018 | ||||||||
|
zinc finger protein 804A | 0.647 | 0.654 | 5.5E-03 |
|
disease | 0.500 | None | 0.961 | 1 | 0 | 2008 | 2019 |